Litigation Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-07-29 |
Court | District Court, D. Delaware | Date Terminated | 2017-11-26 |
Cause | 35:0145 | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,465,504 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc.
Details for Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-11-29 | 35 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504. (Attachments: # 1 … 27 November 2017 1:16-cv-00648 830 Patent None District Court, D. Delaware | External link to document | |
2016-07-29 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504. (nmb) (Entered: 07… 27 November 2017 1:16-cv-00648 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |